Evaluation of BioSewoom(TM) HLA-A, -B, -C PCR/SSP Kit.
10.3343/kjlm.2007.27.5.360
- Author:
Choong Hwan CHA
1
;
Myeong Hee KIM
;
Hee Jung CHUNG
;
Sung Eun CHOI
;
Heung Bum OH
Author Information
1. Department of Laboratory Medicine, University of Ulsan College of Medicine, and Asan Medical Center, Seoul, Korea. hboh@amc.seoul.kr
- Publication Type:Original Article ; Comparative Study ; English Abstract ; Evaluation Studies
- Keywords:
HLA;
SSP;
DNA typing
- MeSH:
Alleles;
Genotype;
HLA-A Antigens/*genetics;
HLA-B Antigens/*genetics;
HLA-C Antigens/*genetics;
Histocompatibility Testing/*methods;
Humans;
Polymerase Chain Reaction/*methods;
Reagent Kits, Diagnostic
- From:The Korean Journal of Laboratory Medicine
2007;27(5):360-368
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Human leukocyte antigen (HLA) typing based on polymerase chain reaction (PCR) is rapidly replacing the conventional serological method. This study was intended to evaluate Bio- SewoomTM HLA-A, -B, -C PCR/SSP kit (BioSewoom SSP) which had recently been developed in Korea. METHODS: A total of 158 samples from domestic (21) and international (137) HLA proficiency testing (PT) were genotyped with BioSewoom SSP, and its results were compared to consensus results. For comparison with INNO-LiPA HLA-A, -B, -C Typing Kit (INNO-LiPA, Innogenetics, Belgium), 20 samples of Koreans were genotyped with both kits for each HLA-A, -B, -C locus. RESULTS: Among the 21 samples of domestic PT, BioSewoom SSP showed ambiguities as follows: 4 samples (19.0%) in HLA-A, 6 (28.6%) in HLA-B, and 1 (4.8%) in HLA-C. The ambiguities could be resolved by considering the allele distribution of Koreans. Among the 137 samples from international PT, BioSewoom SSP also showed ambiguities as follows: 12 samples (8.8%) in HLA-A, 26 (19.0%) in HLA-B and 6 (4.4%) in HLA-C. Considering the allele distribution of Koreans, the serologic equivalents obtained from BioSewoom SSP showed a full agreement with those of INNO-LiPA in all the loci tested. Twelve (0.007%) among 1,760 PCR reactions from the 21 samples of domestic PT and 20 patient samples produced faint nonspecific bands, but it was negligible. PCR failure of internal control just barely occurred (15 PCR reactions, 0.009%), but it had no bearing on allele assignment. CONCLUSIONS: The performance of BioSewoom SSP was comparable to that of INNO-LiPA. All the ambiguities could be resolved by considering the allele distribution of Koreans. It is concluded that BioSewoom SSP has good performance to be used in routine HLA laboratories.
